Anti-androgenic drugs are treatments for androgen-related disorders such as benign prostatic hyperplasia, acne, hirsutism, and androgenic alopecia. Germacrone (1), a sesquiterpene isolated from hexane extracts of Curcuma aeruginosa Roxb. rhizome, is an androgen inhibitor of steroid 5-alpha reductase invitro. Here, we used the similarity of germacrone's α,ß-unsaturated carbonyl to testosterone's α,ß-unsaturated carbonyl to find germacrene analogs obtained from this plant and by semi-synthesis that might be more potent steroid 5-alpha reductase inhibitors. 8-Hydroxy germacrene B (4) was ~13-fold more potent than its parent, 1 and the most potent (IC 50 , 0.15±0.022 mM) among 9 compounds tested. The conformation of its cyclodecadiene ring and the α,ß-unsaturated ketone/hydroxy in the germacrene molecule might be crucial role for its anti-androgen activity. Moreover, 1 and 4 showed mild cytotoxic effect on prostate cancer cells. Neither compound was cytotoxic towards human dermal papilla cells at 100 µg/mL. We show that this SAR strategy created promising anti-androgenics for androgen dependent disorders and may create further analogues with further improvements in selectivity and clinical efficacy.
Androgen over-production can cause disorders such as male-pattern baldness (androgenic alopecia), acne, benign prostatic hyperplasia (BPH), hirsutism, etc. [1] [2] [3] [4] [5] [6] . The steroid 5-reductase plays an important role in converting the androgen, testosterone to the more biologically active dihydrotestosterone (DHT) [6] . To overcome androgen-related pathologies, anti-androgenic drugs that inhibit steroid 5-reductase might be an efficacious treatment target and compounds such as finasteride, epristeride, dutasteride, MK-386, and ethinyl estradiol have already been applied clinically [1, [7] [8] [9] [10] . However, those 5-reductase inhibitors having a steroidal skeleton have adverse side effects [9, [11] [12] [13] . Thus, an appropriate strategy would be the development of non-steroidal anti-androgens.
Steroid 5-reductase is thought to interact at the α,ß-unsaturated ketone in testosterone to form an enolate transition intermediate which transforms to dihydrotestosterone with stereospecific hydride donation from nicotinamide adenine dinucleotide phosphate (NADPH) (Figure 1a ) [9, 14, 15] . In our previous studies, germacrone (1) , the sesquiterpene from the rhizomes of Curcuma aeruginosa Roxb., exhibited high steroid 5-reductase inhibitory activity both in-vitro and in vivo [16, 17] . The chemical structure of compound 1 has the α,ß-unsaturated ketone (Figure 1b ) which might nucleophilically interact with steroid 5-reductase thus mimicking testosterone. However, testosterone has an endo-cyclic double bond while 1 has its exo-cyclic double bond. We suggest that the ten-membered ring may flex enough so that the position of the α,ß-unsaturated double bond can optimally interact with steroid 5reductase. Therefore, we sought to demonstrate the importance of this α,ß-unsaturated ketone and the ten-membered ring of germacrene conformation by synthesizing appropriate gemacrene analogs. Then, these compounds were tested for efficacy and toxicity on the androgen-dependent cells, prostate cancer cell (LNCaP) and normal human dermal papilla cell (scalp hair) which would suggest possible clinical application.
Compound 1 (3.1% yield), furanodiene (2) (12.5% yield) and germacrene B (3) (0.1% yield) were isolated from an n-hexane extract of C. aeruginosa rhizome using column chromatography and by recrystallization. Compound 1 was used as the substrate to NPC Natural Product Communications change the ketone portion to give the hydroxyl (4), methoxy (7) and acetyl analogs (8) , including the double bond rearranged analogs (5, 6) and (9) from (2) ( Figure 2 ).
The ketone of 1 was reduced by NaBH 4 to give 8-hydroxy germacrene B (4) (83% yield) as a colorless oil. The hydroxylated compound was heat-sensitive, so the reaction was performed at 0ºC. The conformational isomerism of 4 was confirmed by using low temperature NMR spectroscopy and revealed the existence of 4 different conformers in solution [18] . Germacrenes underwent facile Cope rearrangement to their corresponding elemene derivatives [19, 20] . The germacrenes 1 and 2 were pyrolysed by refluxing at 200-250ºC for 1-2 hr to give the ß-elemenone (5) (80% yield) and furanoelemene (9) (70% yield), respectively. The temperature and time for the Cope rearrangement was varied depending on the substitution [21] . Elemenol (6) was prepared as a colorless oil (34% yield) from the reduction of 5 by NaBH 4 . The effect of cyclodecadiene on the activity could be studied from 6 and the products of the Cope rearrangement reaction, 5 and 9. In addition, 4 was methylated giving 7 (80% yield) or acetylated giving 8 (97% yield). The 1 H-NMR spectra (400 MHz, CDCl 3 ) of 7 and 8 showed broad signals similar to those of 4. The presence of the two major conformers at 25ºC was observed in their 1 H-NMR spectra. The germacrene analogs were tested for inhibitory activity against the conversion of testosterone to DHT in rat liver microsomal homogenate using ethinyl estradiol as a positive control [16, 17, 30] . The method has been validated and showed high correspondence to results from in vivo study using a hamster model [17] . The only synthetic germacrene analogs that had enzymatic activity more than 60% inhibition were 4 and 6 ( Table 1 ). For 4, its IC 50 was 13-fold lower than 1 and 5-fold less than ethinyl estradiol (Table 1 ). This is in agreement with a previous study [18] . The limited yield of compound 6 prevented the construction of a concentration-effect curve. The chemical structure of germacrene with its ten-membered ring showed conformational isomerism, in particular, compounds 1 and 4 showed the presence of 4 conformers [18, 22] . The flexible conformation of 4 and 1 might be another important property for enzymatic binding.
For the structure-activity relationship (SAR) study, germacrene B (3) which comprised only the cyclodecadiene ring and an exodouble bond showed modest steroid 5-reductase inhibition (48.5%). Adding a ketone group to form an α,ß-unsaturated ketone (1) clearly increased the enzyme inhibitory activity. This indicated that properties such as the H-bond acceptor ability of the ketone might be important for interaction with the enzyme. However; the enzyme inhibitory effect of 3 showed that the cyclodecadiene ring could play a role as another pharmacophoric part in the molecule. Moreover, reduction of the ketone group in 1 and 5 to the alcohol analogs, 4 and 6, respectively, notably enhanced the steroid 5-reductase inhibitory activity. This suggested that the hydroxyl substitution at C-8 might also act as H-bond acceptor/donor to the enzyme. Replacement of hydrogen on the hydroxyl group of 4 by the steric demanding substituent was studied by replacement with a methyl or acetyl group yielded the less potent deivsatives 7 and 8, respectively confirming the importance of the hydroxyl. We, therefore, suggest the H-bond acceptor/donor properties of the α,ß-unsaturated carbonyl or hydroxyl group at C-8 is crucial for activity of these germacrene analogs. Moreover, modifying the functional groups might cause a conformational change of the ring portion thereby affecting binding. The ten-membered ring of 1, 2 and 4 were pyrolysed to the rigid elemene analogs, 5, 9 and 6, respectively. Compared to their parent compounds, the enzymatic activities showed some variation as the inhibition decreased by 2-fold in 5, and increased in 6 and 9 (Table 1 ). These results suggested that the conformational change could affect inhibition of steroid 5-reductase. Steroid 5--reductase is requited for androgen-dependent cell proliferation including prostate cancer cells (LNCaP cells) and normal isolated human dermal papilla cells [23, 24] . Our most potent compounds, 1 and 4, were tested against these two androgen dependent cell types. Both compounds were mildly cytotoxic on LNCaP cells (Table 2) although limited solubility prevented the EC 50 of 1 being determined. In contrast, the dermal papilla cell were more resistant to both compounds (>2,293 M). This data suggests that compound 4 is effective at concentrations lower than those producing toxicity.
In conclusions, The α,ß-unsaturated carbonyl of germacrone can emulate testosterone interaction with steroid 5-alpha reductase and this provided a SAR model which enabled the rational synthesis of more potent inhibitors, especially 4 which had higher potency than germacrone and ethinyl estradiol. These inhibitors were also relatively less cytotoxic. Our SAR strategy should produce germacrone analogs with still greater potency, selectivity, and metabolic stability suited to clinical application of dihydrotesteroneinduced pathologies.
Experimental
General experiment procedure: Melting points, Buchi-535 melting point apparatus; .IR, PerkinElmer Spectrum GX, FT-IR spectrophotometer; NMR, Bruker Avance 400 NMR spectrometer; GC-MS, Hewlett Packard 5989 MS Engine model; (Agilent, Santa Clara CA, U.S.A) and HP-5MS capillary column (split ratio 50:1). The GC condition used in this experiment was as follows; initial temperature 50ºC for 5 min, ramp 10ºC/min to 100ºC at an injection Germacrone as an androgen inhibitor of steroid 5-alpha reductase Natural Product Communications Vol. 11 (9) 
Plant material, extraction and isolation:
Rhizomes of C. aeruginosa (50 kg) were collected from Khao Khor, Phetchabun, Thailand. A voucher specimen (collection no Ganiga001) was kept at Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, and at PBM herbarium, Faculty of Pharmacy, Mahidol University, Bangkok. Fresh rhizomes of C. aeruginosa were dried at 50ºC and powdered. The dried powder rhizomes were macerated with hexane (6 L x 3) for 3 days at room temperature and filtered. The filtrates were pooled and evaporated under reduced pressure to afford crude hexane extract of C. aeruginosa (0.6% yield). The hexane crude extract was fractionated by a quick column chromatography (column: 10 x 13 cm) with gradient elution of hexane:CH 2 Cl 2 (100:0 to 0:100) followed by CH 2 Cl 2 to MeOH (100:0 to 0:100). Twenty four fractions (250 mL each) were collected. The fractions 8 to 12 were pooled, evaporated and crystallized with hexane at 4˚C to afford the crystals which were further purified by recrystallization with MeOH twice to afford white crystals of compound 1 (3.1% yield). Compound 2 was isolated from pooled fractions 2 and 3 as a crude oil and kept at 4ºC to give colorless crystals and then was recrystalized with MeOH twice to obtain the pure compound 2 (12.5% yield). Fraction 1 was fractionated by a silica gel column chromatography and eluted with n-heptane, to give colorless oil as compound 3 (0.10% yield). Compounds 1 and 2 were used as the starting materials for the syntheses.
Germacrone (1): white crystal; MP: 55.3-57.0˚C. All spectroscopic data were in agreement with the previous reports [17, 20] .
Furanodiene (2) : white crystal; MP: 68.2-70.4˚C. All spectroscopic data were in agreement with the previous reports [25] .
Germacrene B (3): colorless oil. All spectroscopic data were in agreement with the previous reports [26, 27] .
8-Hydroxy germacrene B (4):
To a solution of 1 (100 mg, 0.43 mmol) in MeOH (5 mL) was added to NaBH 4 solution (170 mg in MeOH 10 mL) in an ice bath. The reaction mixture was stirred at 0ºC for 1 hr. The reaction was diluted with water (5 mL) and the mixture was partitioned with EtOAc (30 mL x 3). The organic portions were collected and dried with anhydrous sodium sulfate and concentrated by evaporation under reduced pressure. Crude product was purified by silica gel column chromatography (EtOAc:Hexane, 1:9) to give 8-hydroxy germacrene B 4 as colorless oil (85% yield) [18] .
Elemenone (5) : A solution of 1 (150 mg) was refluxed in DMSO (20 mL) at 250ºC for 2 hr under a nitrogen atmosphere. After cooling, the mixture was poured into a separating funnel containing 100 mL of water and the mixture was extracted with hexane (50 mL x3). The organic layer was combined and dried over sodium sulfate. The solvent was evaporated and purified on silica gel column chromatography (EtOAc:Hexane, 0.5:9.5) to afford 5 as a colourless oil (120 mg; 80% yield), identified as elemenone [22, 28] .
Elemenol (6) : A solution of 4 (25 mg) in MeOH (5 mL) was added to a solution of NaBH 4 (50 mg in MeOH 10 mL). The reaction mixture was stirred at 0ºC for 1 hr. Then, the reaction mixture was diluted with water (5 mL), and partitioned with EtOAc (30 mL x 3) .
The EtOAc fraction was dried with anhydrous sodium sulfate and evaporated under reduced pressure. The dried product was purified by silica gel column chromatography (EtOAc:Hexane 1:9) to afford compound 6 (8.5 mg, 34% yield) as a colorless oil [22, 28] . (7) : The suspension of NaH (100 mg) in THF (15 mL) was prepared and stirred on an ice-bath. A solution of compound 4 (25 mg, 0.127 mmol) was added to the NaH suspension and the mixture was stirred for 1 hr. Methyl iodide (2 mL x1) was then added and the reaction mixture was refluxed for 48 hr. The reaction mixture was then cooled and MeOH (10 mL) was added and stirred for 30 min. The reaction mixture was evaporated under reduced pressure, and water (10 mL) was added.
8-Methoxy germacrene B
The mixture was partitioned with EtOAc (30 mL x 3). The organic portion was collected and dried with anhydrous sodium sulfate and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (EtOAc:hexane, 0.5:9.5) to give 7 [28] a colorless oil (20 mg, 80% yield).
8-Acetoxy germacrene B (8)
: 4 (80 mg) was stirred in pyridine (2 mL). Acetic anhydride (0.5 mg) was added to the reaction mixture. 4-Dimethylaminopyridine (0.2 mL) was then added and the mixture was stirred at room temperature for 10 hr. The reaction mixture was chromatographed on silica gel column (EtOAc:hexane, 0.5:9.5) to give a colorless oil (83 mg, 97% yield); The spectral data led to the identification of compound 8 as 8-acetoxy germacrene B [28] .
Furanoelemene (9): 2 (170 mg) was heated in DMSO (20 mL) at 200ºC for 1 hr under a nitrogen atmosphere. After cooling, the mixture was poured into a separating funnel containing 100 mL of water and extracted with hexane (50 mL x 3). The hexane extract was dried over sodium sulfate. The solvent was evaporated to obtain a yellow liquid (1.2 g) which was purified by silica gel column chromatography (n-heptane) to afford 120 mg (70% yield) as a colorless oil. The spectroscopic data led to identification of 9 as furanoelemene [25, 29] 
Preparation of steroid 5--reductase and anti-androgen activity evaluation:
The anti-androgen activity of the germacrene analogs was evaluated using the method previously described [17, 18, 30] . Briefly, the microsomal enzyme was prepared from rat liver (6 weeks of age of Sprague Dawley) [30] . The amount of testosterone remaining after enzymatic reaction was determined using HPLC with the UV detection at 254 nm and prednisolone was used as an internal standard for HPLC analysis. Ethinyl estradiol (Sigma-Aldrich, USA) was used as the positive control [10, 30] . Enzymatic inhibition was determined using peak height ratio (r = peak height of testosterone/peak height of prednisolone) as shown in the equation: Enzymatic inhibition (%) = (r of test sample -r of control at 30min)/(r of control at 0 min) -(r of control at 30 min)
Cytotoxic assay on LNCaP and human follicle dermal papilla cells:
LNCaP cells (CRL-1740™) were purchased from ATCC (VA, USA) and human follicle dermal papilla cells were obtained from PromoCell GmbH (Heidelberg, Germany) Each was maintained in a 75 cm 2 culture flask at 37 °C under 5% CO 2 humidified atmosphere.
To examine the germacrene analogs, the LNCaP cells were grown in RPMI-1640 medium (Gibco, Paisley, Scotland) supplemented with 10% fetal bovine serum (FBS) and 1% of 10,000 U/mL penicillin G and 10,000 μg/mL streptomycin (Gibco, Paisley, Scotland). LNCaP cells were seeded into a 96-well plate at ~104 cells/well plate and incubated for 48 h at 37 °C under 5% CO 2 humidified atmosphere. The medium was then changed to serum-free RPMI-1640 medium (without phenol red which interferes with the spectrophotometry) (Gibco, Paisley, Scotland). After removing the medium, the test compounds were added for another 24 hr. Human follicle dermal papilla cells were cultured in Follicle Dermal Papilla Cell Growth Medium (PromoCell GmbH, Heidelberg, Germany) which also contained FBS (4%), bovine pituitary extract (0.4%), basic fibroblast growth factor (1 ng/mL). The cells were seeded into 96-well plate, and incubated for 24 hr at 37°C under a 5% CO 2 humidified atmosphere. After the medium had been removed, the test compounds were added into the wells for another 24 hr. Then, 10μL of 5 mg/mL MTT reagent was added and incubated for 2 hr. The medium was removed and the formazan produced in the viable cells was solubilized by adding DMSO:EtOH (1:1 v/v). The absorbance at 595 nm was measured using microplate reader. The % cell viability was determined by comparing the absorbance with the control (non-treated). Paclitaxel (Pharmachemie BV, Netherlands) was used as the positive control for the cytotoxic assay on LNCaP cells.
